This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
TEVA-IRBESARTAN HCTZ
TEVA CANADA LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is TEVA-IRBESARTAN HCTZ discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that TEVA-IRBESARTAN HCTZ 300MG 25MG has been permanently discontinued (last updated June 29, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is TEVA-IRBESARTAN HCTZ not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02330539
Strength
300MG 25MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
IRBESARTAN HYDROCHLOROTHIAZIDE
Tier
Unrated
Last Updated
2024-05-23
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
TEVA-IRBESARTAN HCTZ has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646